Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets

by Medindia Content Team on  June 15, 2006 at 6:56 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

Cadila Gets Tentative USFDA Nod For Pravastatin Sodium Tablets
Cadila Healthcare Ltd has received tentative approval from the USFDA to market Pravastatin Sodium Tablets in the US market.

The tentative approval was given for strengths of 10 mg, 20 mg, 40 mg and 80 mg, the company informed the Bombay Stock Exchange.

The company would market the drug through its US subsidiary Zydus Pharmaceuticals (USA) Inc, following patent expiry, it added.

The drug, which had branded sales of approximately 1.8 billion dollars in the US market during 2005, is a lipid lowering agent.

Source:PTI News

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Hyponatremia 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive